An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer

Hagit Tulchinsky, Einat Shmueli, Arie Figer, Joseph M. Klausner, Micha Rabau

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences